Cardo wins auction for bankrupt Vertebron
This article was originally published in Clinica
Orthopaedic expert Cardo Medical has boosted its product offering after purchasing bankrupt spinal implant firm Vertebron for $1.3m in cash. Vertebron (Stratford, Connecticut) manufactures and sells spinal implants for the lumbar and cervical spine, and for motion preservation technology. Its portfolio includes the PSS pedicle screw system, the SSP semi-constrained cervical plate, anterior cervical and posterior lumbar interbody fusion allografts and the Peek vertebral body replacement devices. According to Los Angeles, California-based Cardo, Vertebron generated around $11m in revenue in 2008. However, in April this year, Vertebron filed for bankruptcy. The acquisition follows an auction approved by the US Bankruptcy Court for the District of Connecticut.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals